These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15344537)

  • 21. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW; Goh KL; Wong BC
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors.
    Gerson LB; Triadafilopoulos G; Sahbaie P; Young W; Sloan S; Robinson M; Miner PB; Gardner JD
    BMC Gastroenterol; 2008 May; 8():15. PubMed ID: 18498663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease.
    Fuchs KH; DeMeester TR; Albertucci M
    Surgery; 1987 Oct; 102(4):575-80. PubMed ID: 3660234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflux monitoring.
    Stein E; Katz PO
    Rev Gastroenterol Disord; 2009; 9(2):E54-62. PubMed ID: 19668126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
    Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical?
    Armstrong D; Emde C; Inauen W; Blum AL
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():3-13. PubMed ID: 1577393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and clinical relevance of proximal esophageal pH monitoring.
    Cool M; Poelmans J; Feenstra L; Tack J
    Am J Gastroenterol; 2004 Dec; 99(12):2317-23. PubMed ID: 15571576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of gastro-esophageal reflux disease].
    Koop H
    Praxis (Bern 1994); 2004 Nov; 93(47):1959-62. PubMed ID: 15656006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2C19 polymorphism and proton pump inhibitors.
    Klotz U; Schwab M; Treiber G
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):2-8. PubMed ID: 15245569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of esophageal and gastric pH measurements in patients with gastro-esophageal reflux disease (GERD).
    DiMarino AJ; Cohen S
    Curr Med Res Opin; 2005 Jan; 21(1):27-36. PubMed ID: 15881473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.
    Richter JE; Pandolfino JE; Vela MF; Kahrilas PJ; Lacy BE; Ganz R; Dengler W; Oelschlager BK; Peters J; DeVault KR; Fass R; Gyawali CP; Conklin J; DeMeester T;
    Dis Esophagus; 2013; 26(8):755-65. PubMed ID: 22882487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract]   [Full Text] [Related]  

  • 38. [GERD guideline].
    Hongo M
    Nihon Rinsho; 2004 Aug; 62(8):1421-6. PubMed ID: 15344529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.